This association was maintained in a multivariate logistic regression analysis (HR, 0.599; 95% CI, 0.368–0.975; p value 0.039), both for type of IBD (CD reference vs. UC), and anti-TNF treatment (IFX reference vs. ADL) (HR, 2.070; 95% CI, 1.269–3.376; p value 0.004 and HR, 1.742; CI 95%, 1.057–2.872; p value 0.030, respectively). Here, TNF is linked to inflammatory bowel disease.